The Polystyrene family, a group of polymers derived from styrene monomers, has garnered significant interest in the realm of drug delivery owing to its diverse properties and applications. Comprising homopolymers and copolymers, polystyrene offers a wide range of options for tailoring drug delivery systems to meet specific therapeutic needs.
Polystyrene's versatility is evident in its ability to be modified for controlled drug release, bioadhesion, and targeted delivery. The inert nature of polystyrene enhances drug stability, ensuring the integrity of pharmaceutical formulations. Additionally, its compatibility with various drugs and other materials allows for the creation of multifunctional delivery platforms.
The Polystyrene family's compatibility with different fabrication techniques, including micro- and nano-scale technologies, positions it as a versatile player in the design of drug carriers. The tunable physicochemical properties of polystyrene contribute to its potential in achieving sustained release profiles and improving drug bioavailability.
In the evolving landscape of drug delivery, the Polystyrene family stands as a promising avenue for researchers and pharmaceutical developers, offering a platform to address challenges associated with conventional drug formulations and pave the way for innovative therapeutic solutions.
